FDA Orange Book β Drug Patent & Exclusivity API
Pricing
from $100.00 / 1,000 drug patent records
FDA Orange Book β Drug Patent & Exclusivity API
Track FDA Orange Book drug patents and exclusivity data. Clean JSON for IP counsel, brand teams and AI agents.
Pricing
from $100.00 / 1,000 drug patent records
Rating
0.0
(0)
Developer
NexGenData
Maintained by CommunityActor stats
0
Bookmarked
6
Total users
1
Monthly active users
9 days ago
Last modified
Categories
Share
FDA Orange Book
Track FDA Orange Book drug patents and exclusivity data. Built for IP counsel, brand teams, researchers and AI agents.
Factual public data β not financial or investment advice.
π Sample Output

ingredient | tradeName | dosageFormRoute | applicant | applicantFullName | applicationTypeLabel |
|---|---|---|---|---|---|
| APIXABAN | ELIQUIS SPRINKLE | FOR SUSPENSION;ORAL | BRISTOL | BRISTOL MYERS SQUIBB CO | NDA (brand / innovator) |
| APIXABAN | ELIQUIS | TABLET, FOR SUSPENSION;ORAL | BRISTOL MYERS SQUIBB | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE | NDA (brand / innovator) |
| APIXABAN | APIXABAN | TABLET;ORAL | ACCORD HLTHCARE | ACCORD HEALTHCARE INC | ANDA (generic) |
| APIXABAN | APIXABAN | TABLET;ORAL | ACCORD HLTHCARE | ACCORD HEALTHCARE INC | ANDA (generic) |
| APIXABAN | APIXABAN | TABLET;ORAL | APOTEX | APOTEX INC | ANDA (generic) |
| APIXABAN | APIXABAN | TABLET;ORAL | APOTEX | APOTEX INC | ANDA (generic) |
Real rows from run QZBHZ8ZjhthmR03sM on build 0.0.21 (2026-09-25), unedited apart from masked emails/phones and shortened long text; fields the source does not publish are empty.
π§ Input reference
| Field | Type | Default | What it does |
|---|---|---|---|
ingredient | string | "apixaban" | Filter by active ingredient (contains, case-insensitive). E.g. 'apixaban', 'semaglutide'. |
tradeName | string | Filter by brand name (contains, case-insensitive). E.g. 'Eliquis', 'Ozempic'. | |
applicant | string | Filter by applicant company name (contains, case-insensitive). E.g. 'Pfizer', 'Teva'. | |
applicationNumber | string | Exact NDA/ANDA application number, e.g. '202155'. | |
applicationType | array of string | N = NDA (brand/innovator), A = ANDA (generic). | |
marketingStatus | array of string | RX = prescription, OTC = over-the-counter, DISCN = discontinued. | |
onlyWithUnexpiredPatents | boolean | false | Return only products that still have at least one patent not yet expired. |
patentExpiringAfter | string | Keep products with a patent expiring on/after this date (YYYY-MM-DD). | |
patentExpiringBefore | string | Keep products with a patent expiring on/before this date (YYYY-MM-DD). Useful for finding near-term generic opportunities. | |
includePatents | boolean | true | Include the full array of listed patents per product. |
includeExclusivity | boolean | true | Include the full array of FDA exclusivity entries per product. |
maxResults | integer | 1000 | Maximum number of drug-product records to return. |
π§Ύ JSON sample record
One real record from run QZBHZ8ZjhthmR03sM (emails/phones masked, long text shortened):
{"ingredient": "APIXABAN","tradeName": "ELIQUIS SPRINKLE","dosageFormRoute": "FOR SUSPENSION;ORAL","strength": "0.15MG","applicant": "BRISTOL","applicantFullName": "BRISTOL MYERS SQUIBB CO","applicationType": "N","applicationTypeLabel": "NDA (brand / innovator)","applicationNumber": "220073","productNumber": "001","teCode": null,"approvalDate": "2025-04-17","approvalDateText": "Apr 17, 2025","referenceListedDrug": true,"referenceStandard": true,"marketingStatus": "RX","marketingStatusLabel": "Prescription","patentCount": 4,"exclusivityCount": 2,"earliestProtectionExpiry": "2026-11-21","estimatedGenericEntryDate": "2041-05-22","hasUnexpiredProtection": true,"sourceUrl": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=220073","patents": [{"patentNumber": "11896586","expireDate": "2040-11-22","expireDateText": "Nov 22, 2040","drugSubstance": false,"drugProduct": true,"patentUseCode": "U-4180","delisted": false,"submissionDate": "2025-05-16"},{"patentNumber": "6967208","expireDate": "2026-11-21","expireDateText": "Nov 21, 2026","drugSubstance": true,"drugProduct": true,"patentUseCode": "U-4180","delisted": false,"submissionDate": "2025-05-16"},{"patentNumber": "11896586*PED","expireDate": "2041-05-22","expireDateText": "May 22, 2041","drugSubstance": false,"drugProduct": false,"patentUseCode": null,"delisted": false,"submissionDate": null},{"patentNumber": "6967208*PED","expireDate": "2027-05-21","expireDateText": "May 21, 2027","drugSubstance": false,"drugProduct": false,"patentUseCode": null,"delisted": false,"submissionDate": null}],"exclusivities": [{"exclusivityCode": "NP","expireDate": "2028-04-17"},{"exclusivityCode": "PED","expireDate": "2028-10-17"}]}
π° Pricing
| Event | Price (USD) | When it is charged |
|---|---|---|
Actor Start (apify-actor-start) | $5e-05 | Charged when the Actor starts running. Number of events charged depends on Actor memory (one event per GB, minimum one event). |
Drug patent record (apify-default-dataset-item) | $0.1 | Single result in the default dataset. |
Pay-per-event: you pay only for what the run delivers. A run that delivers nothing bills no result events (only the actor-start event, when the actor defines one). Example: a run that delivers 100 results costs 100 Γ $0.1 = $10.00 plus the start fee.
π Related Actors
More from the NexGenData Healthcare & FDA family:
- FDA Adverse Events β FAERS & MAUDE Records API
- FDA Drug Approvals Tracker β NDA/BLA/ANDA API
- FDA Drug Shortages Monitor β Current & Resolved API
- FDA Pharma Pipeline Tracker β Milestone Data API
- FDA Purple Book β Biologics & Biosimilars API
- FDA Recall Monitor β Drug & Device Safety Alerts
15 more in this family on the NexGenData Store page.
β° Run this as a patent-cliff watch (recommended)
Every IP registry actor is a monitoring subscription, not a one-shot lookup. Schedule a weekly sweep and catch new filings as they land:
{"query": "drug name","limit": 100}
Weekly cron (0 8 * * 1) turns this into an always-on patent-cliff watch.
π What you get
Clean JSON, one record per record (full output has 25 fields):
applicantβ ApplicantapplicantFullNameβ Applicant Full NameapplicationNumberβ Application NumberapplicationTypeβ Application TypeapplicationTypeLabelβ Application Type LabelapprovalDateβ Approval DateapprovalDateTextβ Approval Date TextdosageFormRouteβ Dosage Form RouteearliestProtectionExpiryβ Earliest Protection ExpiryestimatedGenericEntryDateβ Estimated Generic Entry Date
Pricing: $0.10 per record (Pay-Per-Event) β about 10 records per $1.
π€ Use with AI agents
Point Claude, the OpenAI Agents SDK, an n8n flow or any MCP-aware client at it and run FDA Orange Book drug patents and exclusivity on demand.
Sample agent prompt:
List Orange Book patents expiring for a drug and its exclusivity dates.
Agentic payments (x402): Supports agentic payment via x402 β agents can call this actor with USDC, no API key required.
π Related IP actors
Prior-art & patent web: USPTO Patent Search, USPTO Patent Grants, USPTO Grants Tracker, WIPO PatentScope, PatentsView Inventors
IP agent front door: Patents & Trademarks IP MCP
Data from public intellectual-property registries. Factual public data β not financial or investment advice.